---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-020673"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2022-01-28T23:59:59+00:00"
generated_at: "2026-06-27T14:20:02.872286+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ikena Oncology COO & EVP of Finance Douglas Carlson resigns; interim PAA named

## Summary
- Douglas R. Carlson resigns as COO and EVP of Finance, effective Feb 18, 2022, to pursue other opportunities.
- Francisco Oliveira, Head of Finance and Administration since 2019, named interim Principal Accounting Officer.
- Oliveira will report to CEO Mark Manfredi while a formal search for a new CFO is conducted.

## SEC filing metadata
- accession: 0001193125-22-020673
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2022-01-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312522020673/0001193125-22-020673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312522020673/d258896d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-020673
- JSON: https://secwatch.observer/filing/0001193125-22-020673.json
- Plain text: https://secwatch.observer/filing/0001193125-22-020673.txt

## Key facts
- Executive change
  Francisco Oliveira was appointed as Principal Accounting Officer at ImageneBio, Inc..
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: Francisco Oliveira, the Head of Finance and Administration since 2019, will serve as Principal Accounting Officer and report directly to the Company’s Chief Executive Officer, Mark Manfredi, on an interim basis effective as of Mr. Carlson’s departure, while a formal search process to appoint a new Chief Financial Officer is conducted.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312522020673/0001193125-22-020673-index.htm
- Executive change
  Douglas R. Carlson resigned as Chief Operating Officer and Executive Vice President of Finance at ImageneBio, Inc..
  - Action: resigned
  - Role: Chief Operating Officer and Executive Vice President of Finance
  source text: On January 28, 2022, Douglas R. Carlson informed Ikena Oncology, Inc. (the “Company”) of his intent to resign as Chief Operating Officer and Executive Vice President of Finance of the Company to pursue other professional opportunities with broader responsibility.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312522020673/0001193125-22-020673-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.